Program workshopu
Program workshopu
Sunday 16.4.2023
14.00-15.00
Advisory board GSK
(closed meeting for invited guests)
Pálava
15.00-17.00
CMG board meeting – ongoing projects and trials
(closed meeting for CMG board and invited guests)
Pálava
17.00-19.00
Working groups meetings
(closed sessions for invited guests)
Flow cytometry in monoclonal gammopathies working group
(meeting room Tramín)
Coordinator T. Jelínek
Myeloma research groups
(meeting room Müller)
Coordinator S. Ševčíková
Diagnostic methods working group – genomics and
cytogenetics
(meeting room Frankovka)
Coordinator M. Jarošová
Biochemical methods working group
(meeting room Veltlín)
Coordinator J. Vávrová
Imaging in myeloma working group
(meeting room Thurgau)
Coordinator M. Havel
20.00-22.00
Dinner
hotel Galant
Monday 17.4.2023
Morning business meetings
Müller
07.15-08.00
Biobanking project
R. Hájek + participating centers (closed session)
08.00-09.00
CMG study investigators
R. Hájek + participating centers (closed session)
08.00-12.00
Data management education session
(parallel to main program)
Chairs: J. Kopečková (Brno), V. Maisnar (HK),
M. Štork (Brno)
8.00 - 8.45
RMG structure - incorporated changes (IBA , Kopečková)
8.45 – 10.00
RMG Clinical Manual - introduction + presentation of the most frequently discussed problems (Kopečková)
10.00 – 10.15 Coffee break
10.15 – 10.45
RMG data processing process, resulting analysis (IBA)
10.45 – 11.15
RMG summary - coordination of data entry at centers, corrections or additions to data, planned changes to the structure, control plan (Kopečková)
11.15 - 12.00
Issues of assessment of treatment response according to FLC - specific examples (RMG working group representative)
Sauvignon
09.00-12.00
Main program
9.00 – 9.15 Welcome and introduction (R. Hájek, Ostrava)
9.15 – 10.15 Working groups session
Chairs: R. Hájek (Ostrava), J. Minařík (Olomouc)
- What's new in cytogenetics ? M. Jarošová et al.
- What's new in flow ? T. Jelinek et al.
- What's new in science ? S. Ševčíková et al.
- What's new in biochemistry ? J. Vávrová et al.
- What's new in PET/CT ? M. Havel et al.
10.15 – 11.45 Scientific session for clinicians
Chairs: S. Ševčíková (Brno), Z. Chyra (Ostrava)
- The future of mass spectrometry in the diagnosis and assessment of response to treatment of MM, N. Puig (Salamanca, Spain – online) 30 min (supported by Amgen)
- Introduction to immunotherapy, M. Šimíček (Ostrava) 15 min
- CAR-T cells, P. Otáhal (Praha) 15 min
- NK cells, T. Feglarová (Praha) 15 min
Aurelius
12.00-13.30
Lunch
13.30-14.30
Workshop - Challenges in Immunotherapy
Chairs: R. Hájek (Ostrava), V. Maisnar (Hradec Králové)
- Review on antibody drug conjugates, J. Minařík (Olomouc) 8 min
- Review on bispecific antibodies, T. Jelínek (Ostrava) 8 min
- Review on CAR-T, L. Pour (Brno) 8 min
- Specific toxicities of CAR-T and BsAb, A. Jungová (Plzeň) 8 min
- Infections after immunotherapy, J. Radocha (Hradec Králové) 8 min
- Panel discussion (all)
Aurelius
14.30-15.00
Coffee break
15.00-16.00 Industry sponsored sympozium (Takeda)
Pozice léku Ninlaro v sekvenci léčby mnohočetného myelomu
(Ninlaro position in therapy sequencing strategies in multiple myeloma)
Uvítání (Welcome)
Roman Hájek
Treatment of lenalidomide-exposed patients and position of Ninlaro in the treatment sequence (Léčba pacientů, kteří již byli léčeni lenalidomidem a pozice léku Ninlaro v léčebné sekvenci)
Karthik Ramasamy
Léčba lékem Ninlaro ve Fakultní nemocnici Ostrava (Ninlaro use in University Hospital in Ostrava)
Tereza Popková
Léčba lékem Ninlaro ve Fakultní nemocnici Brno (Ninlaro use in University Hospital Brno)
Martin Štork
Discussion (Diskuze)
Všichni (All)
Speakers:
Roman Hájek, Prof., MUDr., CSc. – FN Ostrava
Karthik Ramasamy, MBBS FRCP FRCPath PhD – Oxford University Hospitals NHS Trust
Martin Štork, MUDr., PhD. – FN Brno
Tereza Popková, MUDr. – FN Ostrava
16.10 – 17.10 Industry sponsored symposium (Janssen)
Revoluce v léčbě mnohočetného myelomu
prof. MUDr. Roman Hájek, CSc. (FN Ostrava)
MUDr. Alexandra Jungová, Ph.D. (FN Plzeň)
prof. MUDr. Vladimír Maisnar, Ph.D. (FN Hradec Králové)
doc. MUDr. et Mgr. Jiří Minařík, Ph.D. (FN Olomouc)
MUDr. Petr Pavlíček (FN Královské Vinohrady)
prof. MUDr. Luděk Pour, Ph.D. (FN Brno)
prof. MUDr. Ivan Špička, CSc. (VFN Praha)
Moderuje:
Lenka Fikrová (Janssen)
17.20 – 18.20 Industry sponsored symposium (Sanofi)
Budoucnost léčby mnohočetného myelomu
Předsedající:
doc. MUDr., Mgr. Jiří Minařík, Ph.D.
Přednášející:
Prof. MUDr. Luděk Pour, Ph.D.
Kombinace Isa+Pd je efektivní i u velice předléčených pacientů – kazuistika z reálné klinické praxe
Prof. MUDr. Roman Hájek, CSc.
Jak využití výsledků studie IKEMA může ovlivnit reálnou praxi
Aurelius
19.30-20.40
Evening ceremony of the 21st workshop
Prof. Otto Kahler Award - doc. MUDr. Martin Mistrík, CSc
Chair: R. Hájek (Ostrava)
Mikulov castle
21.00-02.00
Gala dinner
hotel Galant
Tuesday 18.4.2023
08.15-08.45
Annual meeting of CMG members (CZ)
Chairs: R. Hájek (Ostrava), M. Krejčí (Brno)
- Annual report (R. Hájek, Ostrava) 10 min
- Steering committee report (M. Krejčí, Brno) 10 min
- Guidelines 2023 – Multiple myeloma (R. Hajek, Ostrava)
10 min
08.45 – 09.45 Industry sponsored symposium (Amgen)
10.00 – 11.00 Workshop: Rare monoclonal gammopathies
Chairs: Z. Adam (Brno), M. Kaščák (Ostrava)
- Overview of rare monoclonal gammopathies (Z. Adam, Brno) 15 + 5 min
- LCDD, L. Pour (Brno), 8 + 2 min
- POEMS, P. Kessler (Pelhřimov), 8 + 2 min
- Schniztler syndrome, M. Sýkora (České Budějovice), 8 + 2 min
- Localized amyloidosis, T. Pika (Olomouc), 8 + 2 min
11.10 – 12.00 New faces in myeloma: Defining response in myeloma (CZ)
Chairs: J. Ullrychová (Ústí nad Labem), M. Štork (Brno)
- Introduction to the evaluation of treatment response in MM, M. Štork (Brno) 5 min
- Biochemical evaluation of response in MM, F. Sedlák (VFN Praha) 8 min
- Combined assessment of treatment response by flow cytometry and PET/CT, L. Muroňová (Ostrava) 8 min
- PET/MRI as a new perspective method for evaluation of treatment response/MRD, V. Válek jr. (Brno KRNM) 8 min
- Evaluation of therapeutic response in multiple myeloma in relation to RMG data entry, T. Popková (Ostrava) 8 min
- Discussion